Zydus secures Mexico’s COFEPRIS approval for its biosimilar ‘Bhava’ to treat various cancers
Zydus Lifesciences receives approval to market Bhava™ for various cancers in Mexico, expanding access to affordable oncology treatments
Zydus Lifesciences receives approval to market Bhava™ for various cancers in Mexico, expanding access to affordable oncology treatments